首页> 美国卫生研究院文献>Pharmaceutics >Novel Drug Delivery Systems Fighting Glaucoma: Formulation Obstacles and Solutions
【2h】

Novel Drug Delivery Systems Fighting Glaucoma: Formulation Obstacles and Solutions

机译:新型药物递送系统对抗青光眼:配方障碍和解决方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Glaucoma is considered to be one of the biggest health problems in the world. It is the main cause of preventable blindness due to its asymptomatic nature in the early stages on the one hand and patients’ non-adherence on the other. There are several approaches in glaucoma treatment, whereby this has to be individually designed for each patient. The first-line treatment is medication therapy. However, taking into account numerous disadvantages of conventional ophthalmic dosage forms, intensive work has been carried out on the development of novel drug delivery systems for glaucoma. This review aims to provide an overview of formulation solutions and strategies in the development of in situ gel systems, nanosystems, ocular inserts, contact lenses, collagen corneal shields, ocular implants, microneedles, and iontophoretic devices. The results of studies confirming the effectiveness of the aforementioned drug delivery systems were also briefly presented.
机译:青光眼被认为是世界上最大的健康问题之一。它是由于其早期阶段的无症状的预防失明的主要原因是另一方面的患者的非粘附性。青光眼处理有几种方法,从而必须为每位患者单独设计。一线治疗是药物治疗。然而,考虑到常规眼科剂型的许多缺点,对青光眼新药递送系统的开发进行了强化作品。该审查旨在概述制定解决方案和策略在原位凝胶系统,纳米系统,眼刀片,隐形眼镜,胶原角膜屏蔽,眼部植入物,微针和离子电泳装置中的开发中的制定解决方案和策略。还简要介绍了证实上述药物递送系统的有效性的研究结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号